NO20091267L - Compositions and methods to prevent cancer with cupredoxins - Google Patents

Compositions and methods to prevent cancer with cupredoxins

Info

Publication number
NO20091267L
NO20091267L NO20091267A NO20091267A NO20091267L NO 20091267 L NO20091267 L NO 20091267L NO 20091267 A NO20091267 A NO 20091267A NO 20091267 A NO20091267 A NO 20091267A NO 20091267 L NO20091267 L NO 20091267L
Authority
NO
Norway
Prior art keywords
cupredoxins
compositions
methods
prevent cancer
cancer
Prior art date
Application number
NO20091267A
Other languages
Norwegian (no)
Inventor
Ananda Chakrabarty
Tapas Das Gupta
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Publication of NO20091267L publication Critical patent/NO20091267L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
NO20091267A 2006-09-14 2009-03-26 Compositions and methods to prevent cancer with cupredoxins NO20091267L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84435806P 2006-09-14 2006-09-14
PCT/US2007/078371 WO2008033987A2 (en) 2006-09-14 2007-09-13 Compositions and methods to prevent cancer with cupredoxins

Publications (1)

Publication Number Publication Date
NO20091267L true NO20091267L (en) 2009-06-04

Family

ID=39184582

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091267A NO20091267L (en) 2006-09-14 2009-03-26 Compositions and methods to prevent cancer with cupredoxins

Country Status (13)

Country Link
EP (1) EP2061498A4 (en)
JP (2) JP2010503409A (en)
KR (1) KR20090059152A (en)
CN (1) CN101595124A (en)
AU (1) AU2007296429A1 (en)
BR (1) BRPI0714987A2 (en)
CA (1) CA2663498A1 (en)
IL (1) IL197602A0 (en)
MX (1) MX2009002787A (en)
NO (1) NO20091267L (en)
RU (1) RU2009113812A (en)
SG (1) SG174784A1 (en)
WO (1) WO2008033987A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9096663B2 (en) 2001-02-15 2015-08-04 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
US7381701B2 (en) 2001-02-15 2008-06-03 The Borad Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
US7556810B2 (en) 2005-07-19 2009-07-07 The Board Of Trustees Of The University Of Ilinois Compositions and methods to control angiogenesis with cupredoxins
US10675326B2 (en) 2004-10-07 2020-06-09 The Board Of Trustees Of The University Of Illinois Compositions comprising cupredoxins for treating cancer
US9598470B2 (en) 2004-10-07 2017-03-21 Craig W. Beattie Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways
UA97466C2 (en) 2004-10-07 2012-02-27 Ананда Чакрабарти Cupredoxin derived transport agents and methods of use thereof
US9434770B2 (en) 2004-10-07 2016-09-06 Tapas K Das Gupta Modified cupredoxin derived peptides
US9968685B2 (en) 2004-10-07 2018-05-15 Brad N. Taylor Methods to treat cancer with cupredoxins
JP2009502135A (en) 2005-07-19 2009-01-29 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ Transport factors for crossing the blood-brain barrier and into brain cancer cells and methods of use thereof
MX2009005849A (en) 2006-12-04 2009-08-12 Univ Illinois Compositions and methods to treat cancer with cupredoxins and cpg rich dna.
EP2114429A4 (en) 2007-02-08 2010-05-19 Univ Illinois Compositions and methods to prevent cancer with cupredoxins
KR20200058421A (en) * 2017-09-29 2020-05-27 온크그노스틱스 게엠베하 Determination of risk for neoplasia and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491394B2 (en) * 2001-02-15 2009-02-17 The Board Of Trustees Of The University Of Illinois Cytotoxic factors for modulating cell death
CN1506375A (en) * 2002-12-12 2004-06-23 浙江养生堂天然药物研究所有限公司 Azurin as bacterial protein with wide-spectrum antitumor function and its use and medicinal composition
UA97466C2 (en) * 2004-10-07 2012-02-27 Ананда Чакрабарти Cupredoxin derived transport agents and methods of use thereof
JP2008539795A (en) * 2005-05-20 2008-11-20 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ Compositions and methods for treating symptoms related to ephrin signaling using cupredoxins
JP2009502797A (en) * 2005-07-19 2009-01-29 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ Compositions and methods for controlling angiogenesis with cupredoxins

Also Published As

Publication number Publication date
JP2010503409A (en) 2010-02-04
KR20090059152A (en) 2009-06-10
WO2008033987A2 (en) 2008-03-20
SG174784A1 (en) 2011-10-28
AU2007296429A1 (en) 2008-03-20
WO2008033987A3 (en) 2009-04-30
RU2009113812A (en) 2010-10-20
BRPI0714987A2 (en) 2013-07-30
EP2061498A2 (en) 2009-05-27
CN101595124A (en) 2009-12-02
EP2061498A4 (en) 2009-11-04
IL197602A0 (en) 2011-08-01
MX2009002787A (en) 2009-08-27
CA2663498A1 (en) 2008-03-20
JP2014050390A (en) 2014-03-20

Similar Documents

Publication Publication Date Title
NO20091267L (en) Compositions and methods to prevent cancer with cupredoxins
NO20200775A1 (en) Methods and compositions for treating cancer
CR10667A (en) COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER
DK2063907T3 (en) METHODS AND COMPOSITIONS BASED ON DIFTERY TOXIN-INTERLEUKIN-3 CONJUGATES
BRPI0716325A2 (en) ANTIMICROBIAN COMPOSITION
SMAP200900058A (en) Compounds and compositions as proteinachinase inhibitors
SM201000108B (en) Compounds and compositions as proteinachinase inhibitors
SMAP200900020A (en) Compounds and compositions as proteinachinase inhibitors
SMAP200900031A (en) Compounds and compositions as proteinachinase inhibitors
FR2899479B1 (en) CICATRISANTE COMPOSITION
EP2041267A4 (en) Compositions and methods for enhancing glycerol utilization
DK2185164T3 (en) COMPOSITION AND THERAPEUTIC ANTITUMORVACCINE
DK1984009T3 (en) Pharmaceutical compositions with improved stability
DK3263589T5 (en) PEPTIME SEQUENCES AND COMPOSITIONS
IL200251A0 (en) Compositions and methods to prevent cancer with cupredoxins
DK2373293T3 (en) COMPOSITIONS WITH REDUCED DIMERING
NO20081287A (en) Fuel composition and process for its preparation
ATE529092T1 (en) ANTIPERSPIRANT COMPOSITIONS
DK3363857T3 (en) HYBRIDE HIGH POLYMER CONTENT REDUCING COMPOSITIONS
BRPI0905715A2 (en) Pharmaceutical Composition and Component Kit
BRPI0716458A2 (en) VOLCANIZED COMPOSITION
BRPI0812932A2 (en) CANCER TREATMENT COMPOSITIONS AND METHODS
DK2152699T3 (en) Quinolone Compound and Pharmaceutical Composition
DK2334596T3 (en) FERRIPHOSPHATE BASED COMPOSITION AND APPLICATION THEREOF
EP2029132A4 (en) Anti-histamine compositions and use thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application